- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/62 - Insulins
Patent holdings for IPC class C07K 14/62
Total number of patents in this class: 1038
10-year publication summary
|
92
|
69
|
79
|
75
|
92
|
76
|
74
|
63
|
65
|
56
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novo Nordisk A/S | 2281 |
77 |
| Case Western Reserve University | 1841 |
57 |
| Hanmi Pharm. Co., Ltd. | 574 |
38 |
| Modernatx, Inc. | 1283 |
33 |
| Merck Sharp & Dohme LLC | 3753 |
30 |
| Eli Lilly and Company | 3902 |
26 |
| Sanofi | 4097 |
20 |
| Sanofi-Aventis Deutschland GmbH | 2621 |
18 |
| Biocon Limited | 222 |
18 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
17 |
| Dechra Limited | 114 |
17 |
| Merck Sharp & Dohme Corp. | 2190 |
16 |
| Akston Biosciences Corporation | 34 |
16 |
| Ecole Polytechnique Federale de Lausanne (epfl) | 1557 |
14 |
| Quiapeg Pharmaceuticals AB | 45 |
13 |
| Protomer Technologies, Inc. | 18 |
12 |
| Indiana University Research and Technology Corporation | 801 |
11 |
| The Trustees of Indiana University | 756 |
11 |
| Codexis, Inc. | 801 |
10 |
| Imcyse SA | 74 |
10 |
| Other owners | 574 |